enVVeno Medical (NVNO) Competitors $0.78 0.00 (-0.59%) Closing price 09/12/2025 04:00 PM EasternExtended Trading$0.80 +0.02 (+2.00%) As of 09/12/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NVNO vs. SURG, DXR, PYPD, SRTS, CTCX, APT, MDAI, MLSS, PSTV, and GUTSShould you be buying enVVeno Medical stock or one of its competitors? The main competitors of enVVeno Medical include SurgePays (SURG), Daxor (DXR), PolyPid (PYPD), Sensus Healthcare (SRTS), Carmell (CTCX), Alpha Pro Tech (APT), Spectral AI (MDAI), Milestone Scientific (MLSS), Plus Therapeutics (PSTV), and Fractyl Health (GUTS). These companies are all part of the "medical equipment" industry. enVVeno Medical vs. Its Competitors SurgePays Daxor PolyPid Sensus Healthcare Carmell Alpha Pro Tech Spectral AI Milestone Scientific Plus Therapeutics Fractyl Health enVVeno Medical (NASDAQ:NVNO) and SurgePays (NASDAQ:SURG) are both small-cap medical equipment companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk. Do institutionals & insiders have more ownership in NVNO or SURG? 34.7% of enVVeno Medical shares are held by institutional investors. Comparatively, 6.9% of SurgePays shares are held by institutional investors. 16.0% of enVVeno Medical shares are held by insiders. Comparatively, 30.5% of SurgePays shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Do analysts prefer NVNO or SURG? SurgePays has a consensus target price of $9.00, indicating a potential upside of 203.03%. Given SurgePays' stronger consensus rating and higher probable upside, analysts clearly believe SurgePays is more favorable than enVVeno Medical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score enVVeno Medical 0 Sell rating(s) 1 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 2.00SurgePays 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer NVNO or SURG? In the previous week, SurgePays had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 3 mentions for SurgePays and 2 mentions for enVVeno Medical. SurgePays' average media sentiment score of 0.86 beat enVVeno Medical's score of 0.45 indicating that SurgePays is being referred to more favorably in the news media. Company Overall Sentiment enVVeno Medical Neutral SurgePays Positive Which has preferable valuation and earnings, NVNO or SURG? enVVeno Medical has higher earnings, but lower revenue than SurgePays. SurgePays is trading at a lower price-to-earnings ratio than enVVeno Medical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioenVVeno MedicalN/AN/A-$21.82M-$1.20-0.65SurgePays$60.88M1.00-$45.73M-$2.49-1.19 Which has more risk & volatility, NVNO or SURG? enVVeno Medical has a beta of 0.87, meaning that its share price is 13% less volatile than the S&P 500. Comparatively, SurgePays has a beta of 0.43, meaning that its share price is 57% less volatile than the S&P 500. Is NVNO or SURG more profitable? enVVeno Medical has a net margin of 0.00% compared to SurgePays' net margin of -133.85%. enVVeno Medical's return on equity of -57.35% beat SurgePays' return on equity.Company Net Margins Return on Equity Return on Assets enVVeno MedicalN/A -57.35% -53.49% SurgePays -133.85%-333.87%-195.36% SummaryenVVeno Medical beats SurgePays on 8 of the 15 factors compared between the two stocks. Get enVVeno Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NVNO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NVNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NVNO vs. The Competition Export to ExcelMetricenVVeno MedicalMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$15.13M$6.95B$5.87B$10.14BDividend YieldN/A1.21%5.68%4.59%P/E Ratio-0.6525.5274.5225.93Price / SalesN/A192.52549.78198.13Price / CashN/A22.1337.5660.44Price / Book0.335.0012.166.29Net Income-$21.82M$176.38M$3.28B$270.77M7 Day Performance1.10%1.00%0.87%3.88%1 Month Performance-82.94%0.74%4.96%4.88%1 Year Performance-85.48%10.34%60.74%26.01% enVVeno Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NVNOenVVeno Medical0.6197 of 5 stars$0.78-0.6%N/A-85.1%$15.13MN/A-0.6530Short Interest ↑Gap UpSURGSurgePays3.1066 of 5 stars$2.79+1.1%$9.00+222.6%+102.0%$56.39M$60.88M-1.1240Negative NewsDXRDaxor4.0913 of 5 stars$11.40-0.1%$25.00+119.3%+24.4%$55.19MN/A0.0037Short Interest ↓Gap DownPYPDPolyPid3.3814 of 5 stars$3.49+0.9%$12.40+255.3%-3.3%$55MN/A0.0080Positive NewsShort Interest ↓SRTSSensus Healthcare2.6578 of 5 stars$3.27+1.2%$8.00+144.6%-45.6%$53.10M$41.81M0.0040CTCXCarmellN/A$2.43-4.7%N/A+482.1%$50.80M$32.84K0.0014APTAlpha Pro Tech2.6646 of 5 stars$4.85-0.8%N/A-14.2%$50.79M$58.56M13.11120News CoverageShort Interest ↓High Trading VolumeMDAISpectral AI2.9261 of 5 stars$1.86-0.5%$3.50+88.2%+49.2%$49.99M$27.55M-2.7083MLSSMilestone Scientific2.6829 of 5 stars$0.63+3.9%$1.25+98.4%-38.2%$49.49M$9.08M-9.0030Positive NewsShort Interest ↓Gap DownPSTVPlus Therapeutics3.236 of 5 stars$0.49+3.2%$7.88+1,496.4%-68.7%$47.43M$5.82M0.0020Short Interest ↑GUTSFractyl Health2.1202 of 5 stars$0.97+4.6%$6.53+571.9%-64.3%$46.74M$90K0.00102 Related Companies and Tools Related Companies SURG Alternatives DXR Alternatives PYPD Alternatives SRTS Alternatives CTCX Alternatives APT Alternatives MDAI Alternatives MLSS Alternatives PSTV Alternatives GUTS Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NVNO) was last updated on 9/13/2025 by MarketBeat.com Staff From Our PartnersWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredForget Tesla — This Tiny AI Stock Is Musk’s Real PlayWhile Wall Street focused on Tesla’s earnings, Elon Musk was quietly building a supercomputer so powerful it c...Behind the Markets | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | Sponsored“Sell Nvidia before earnings”Eric Fry just went live with one of his most controversial calls yet: “Sell Nvidia.” While Wall Street has bee...InvestorPlace | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding enVVeno Medical Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share enVVeno Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NVNO Stock Alerts